Alkermes plc. Foreign Income Tax Expense (Benefit), Continuing Operations
Alkermes plc. (ALKS) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $4.40 million for the 3-month period ending 2012-12-31, per its 10-Q filed 2013-01-31.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2013-01-31
- Alkermes plc. foreign income tax expense (benefit), continuing operations for the quarter ending 2012-12-31 was $4.40M.
- Alkermes plc. foreign income tax expense (benefit), continuing operations for the quarter ending 2012-09-30 was $400.00K.
- Alkermes plc. foreign income tax expense (benefit), continuing operations for the quarter ending 2012-06-30 was $800.00K.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month |
|---|---|---|---|
| 2012-12-31 | $4.40M 10-Q · filed 2013-01-31 | $4.80M derived: sum of 2 quarters · filed 2013-01-31 | $5.60M 10-Q · filed 2013-01-31 |
| 2012-09-30 | $400.00K 10-Q · filed 2012-11-01 | $1.20M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $800.00K 10-Q · filed 2012-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |